-
Je něco špatně v tomto záznamu ?
The incidence of MYB gene breaks in adenoid cystic carcinoma of the salivary glands and its prognostic significance
M. Broz, P. Steiner, R. Salzman, L. Hauer, I. Starek
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
27174194
DOI
10.5507/bp.2016.027
Knihovny.cz E-zdroje
- MeSH
- adenoidně cystický karcinom genetika mortalita MeSH
- dospělí MeSH
- genetická predispozice k nemoci genetika MeSH
- geny myb genetika MeSH
- hybridizace in situ fluorescenční MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory slinných žláz genetika mortalita MeSH
- prognóza MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: To detect MYB gene breaks in adenoid cystic carcinoma (ACC) of the salivary glands and its correlation with prognosis and selected clinical parameters METHODS: MYB gene break was detected by FISH assay in 23 adenoid cystic carcinomas using formalin-fixed paraffin-embedded blocks. The Kaplan-Meier survival analysis was used to estimate prognosis. RESULTS: Fifteen of 23 evaluated tumours were MYB positive and 8 MYB negative. The 10-year cumulative survival, respectively disease free interval, was 60.0%, respectively 59.3%, in MYB positive patients and 88.5%, respectively 80.0%, in MYB negative patients (long rank test, P=0.23). There were no significant differences in age, gender, perineural invasion, the presence of hematogenic or nodal metastases or degree of histopathological grading between MYB positive and MYB negative patients. CONCLUSION: A tendency to differences in the survival of patients with ACC, depending on their MYB status. MYB negative patients were predisposed to better prognosis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17016667
- 003
- CZ-PrNML
- 005
- 20170519133135.0
- 007
- ta
- 008
- 170516s2016 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2016.027 $2 doi
- 035 __
- $a (PubMed)27174194
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Brož, Martin, $u Department of Otorhinolaryngology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1965- $7 xx0102589
- 245 14
- $a The incidence of MYB gene breaks in adenoid cystic carcinoma of the salivary glands and its prognostic significance / $c M. Broz, P. Steiner, R. Salzman, L. Hauer, I. Starek
- 520 9_
- $a AIMS: To detect MYB gene breaks in adenoid cystic carcinoma (ACC) of the salivary glands and its correlation with prognosis and selected clinical parameters METHODS: MYB gene break was detected by FISH assay in 23 adenoid cystic carcinomas using formalin-fixed paraffin-embedded blocks. The Kaplan-Meier survival analysis was used to estimate prognosis. RESULTS: Fifteen of 23 evaluated tumours were MYB positive and 8 MYB negative. The 10-year cumulative survival, respectively disease free interval, was 60.0%, respectively 59.3%, in MYB positive patients and 88.5%, respectively 80.0%, in MYB negative patients (long rank test, P=0.23). There were no significant differences in age, gender, perineural invasion, the presence of hematogenic or nodal metastases or degree of histopathological grading between MYB positive and MYB negative patients. CONCLUSION: A tendency to differences in the survival of patients with ACC, depending on their MYB status. MYB negative patients were predisposed to better prognosis.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a adenoidně cystický karcinom $x genetika $x mortalita $7 D003528
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a geny myb $x genetika $7 D020570
- 650 _2
- $a genetická predispozice k nemoci $x genetika $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hybridizace in situ fluorescenční $7 D017404
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a nádory slinných žláz $x genetika $x mortalita $7 D012468
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šteiner, Petr $u Bioptic Laboratory Ltd, Molecular Pathology Laboratory, Pilsen and Department of Pathology, Faculty of Medicine in Plzen, Charles University in Prague, Pilsen, Czech Republic $7 xx0229671
- 700 1_
- $a Salzman, Richard $u Department of Otorhinolaryngology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 jx20061107011
- 700 1_
- $a Hauer, Lukáš, $u Department of Maxillofacial Surgery, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic $d 1980- $7 xx0138820
- 700 1_
- $a Stárek, Ivo, $u Department of Otorhinolaryngology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1951- $7 jn20001103574
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 3 (2016), s. 417-422
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170516 $b ABA008
- 991 __
- $a 20170518094028 $b ABA008
- 999 __
- $a ok $b bmc $g 1205813 $s 977476
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 3 $d 417-422 $e 20160512 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20170516
